Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in SMMT — Summit Therapeutics Inc.

CIK 70858 CHARLOTTE, NC
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,602,801
+$1,251,602 QoQ
Shares Held
864,983
+44.5% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 242 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. SMMT ranks #105 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in SMMT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,602,801 864,983
2026-03-31 $11,351,199 598,692
2025-12-31 $8,349,601 477,393
2025-09-30 $13,580,082 657,313
2025-06-30 $12,047,606 566,147
2025-03-31 $7,122,291 369,222
2024-12-31 $7,701,330 431,568
2024-09-30 $8,555,453 390,660
2024-06-30 $2,660,946 341,147
2024-03-31 $1,616,019 390,343
2023-12-31 $319,181 122,292
2023-09-30 $119,776 64,052
2023-06-30 $24,035 9,576
2023-03-31 $28,570 16,326
2022-12-31 $38,045 8,952
2022-09-30 $2,003 1,684
2022-06-30 $206 206
2022-03-31 $23,995 9,794
2021-12-31 $51,946 19,311
2021-09-30 $57,579 11,493
2021-06-30 $64,826 8,690
2021-03-31 $248,077 42,262
2020-12-31 $48,833 10,390
2020-09-30 $10,320 3,000